U.S. Department of Health and Human Services (HHS) issued the following announcement on May 16.
HHS Secretary Alex Azar issued the following statement regarding the FDA’s approval of the first non-opioid treatment for the symptoms of opioid withdrawal:
“President Trump and HHS have made fighting the opioid crisis a top priority. That includes working to expand the set of tools we have for solving this crisis, such as new therapies for treating opioid use disorder and helping people stay in recovery. The Food and Drug Administration’s approval today of the first non-opioid treatment for managing opioid withdrawal symptoms is a welcome step forward. I applaud the work of the FDA as well as the National Institute on Drug Abuse, which supported clinical studies of the treatment, in prioritizing efforts to prevent and treat opioid addiction. Evidence-based treatment for addiction saves lives, and HHS will continue to support efforts to develop new treatments and provide approved treatments to those in need.”
Read the FDA statement on the approval here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm
Original source can be found here.